Trial Profile
A Study Testing HIV-1 Drug Resistance By Ultra-Deep Sequencing After Short Course Of Zidovudine Single-Dose Of Nevirapine And Single-Dose Of Tenofovir Disoproxil Fumarate With Emtricitabine For Prevention Of Mother-To-Child Transmission (pMTCT).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jan 2017
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Nevirapine (Primary) ; Zidovudine (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Therapeutic Use
- 05 Jan 2017 New trial record
- 01 Dec 2016 Results (n=26) published in the JAIDS:Journal of acquired immune deficiency syndromes.